IGM Biosciences (IGMS) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -30.4 | -4.96 | 1.74 | 1.16 | -1.16 | 1.13 | ||
| Changes by years, y/y, % | +920% | -84% | -135% | -33% | -200% | -17.2% | |||
IGM Biosciences. EV/EBITDA
IGM Biosciences. EV/EBITDA, changes, %
IGM Biosciences (IGMS) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2024Q2 | FY2024Q3 | FY2024Q4 | FY2025Q1 | FY2025Q2 | LTM ? | |||
| EV/EBITDA | ? | 0.95 | -3.68 | -1.16 | 0.21 | 1.13 | 1.13 | |
| Changes by years, y/y, % | -423% | -362% | -200% | -79% | +19% | |||
| Changes by quarters, q/q, % | -8% | -486% | -68% | -118% | +435% | |||